High-dose Bevacizumab in Advanced Renal Carcinoma Patients

NCT00455975 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

119

Enrollment

OTHER

Sponsor class

Conditions

Renal Cancer
Kidney Cancer

Interventions

DRUG: Bevacizumab

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]